Fidelity Funds - Sustainable Health Care Fund I-Acc-EURRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 8.5 | 24.7 | -3.0 | 0.8 | 6.2 | |
+/-Cat | -8.9 | 15.3 | 1.7 | 3.9 | 2.4 | |
+/-B’mrk | - | 6.5 | -8.8 | 3.3 | -1.2 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 22/11/2024 | EUR 21.03 | |
Day Change | 1.32% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU1668149443 | |
Fund Size (Mil) 31/10/2024 | EUR 1712.65 | |
Share Class Size (Mil) 22/11/2024 | EUR 91.66 | |
Max Initial Charge | - | |
Ongoing Charge 30/07/2024 | 0.89% |
Investment Objective: Fidelity Funds - Sustainable Health Care Fund I-Acc-EUR |
The fund aims to achieve capital growth over the long term. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Alex Gold 01/10/2017 | ||
Inception Date 23/08/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI/Health Care NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Funds - Sustainable Health Care Fund I-Acc-EUR | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
UnitedHealth Group Inc | Healthcare | 9.43 |
Boston Scientific Corp | Healthcare | 7.11 |
Eli Lilly and Co | Healthcare | 6.68 |
Novo Nordisk AS Class B | Healthcare | 5.84 |
Stryker Corp | Healthcare | 4.51 |
Increase Decrease New since last portfolio | ||
Fidelity Funds - Sustainable Health Care Fund I-Acc-EUR |